Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORID-HF TRIAL
2024-519878-39-00Phase 4Authorised
- Sponsor
- Università di Padova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic heart failure (CHF) and iron deficiency anemia (IDA) comparing Ferinject + Dibase, Ferinject alone and Other iron/vitamin D strategy (3 arms). Primary endpoint: Six-Minute Walking Test performance. Planned start Jan 2025; status: authorised.
02
Drugs
cholecalciferolferric carboxymaltose
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2024-519878-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519878-39-00.